Assignee
PHARMOSA BIOPHARM INC
TW·6 granted patents·5 pending applications·0 citations·filing 2018–2025
Top patents by PatentIndex Score
11 records- 0178US12220483B2Liposome compositions comprising weak acid drugs and uses thereofPHARMOSA BIOPHARM INC·Filed 2024·Granted Feb 11, 2025·0 cites·20 claims
- 0273US2024050387A1Pharmaceutical composition for controlled release of treprostinilPHARMOSA BIOPHARM INC·Filed 2023·Application pending·0 cites
- 0371US2024374547A1Pharmaceutical composition of a weak acid drug and methods of administrationPHARMOSA BIOPHARM INC·Filed 2024·Application pending·0 cites
- 0469US11833125B2Pharmaceutical composition for controlled release of treprostinilPHARMOSA BIOPHARM INC·Filed 2021·Granted Dec 5, 2023·0 cites·20 claims
- 0567US11229616B2Pharmaceutical composition for controlled release of treprostinilPHARMOSA BIOPHARM INC·Filed 2019·Granted Jan 25, 2022·0 cites·18 claims
- 0664US12551437B2Liposome compositions comprising weak acid drugs and uses thereofPHARMOSA BIOPHARM INC·Filed 2025·Granted Feb 17, 2026·0 cites·20 claims
- 0764US11964050B2Liposome compositions comprising weak acid drugs and uses thereofPHARMOSA BIOPHARM INC·Filed 2018·Granted Apr 23, 2024·0 cites·13 claims
- 0861US2025241856A1Pharmaceutical composition for controlled release of weak acid drugs and uses thereofPHARMOSA BIOPHARM INC·Filed 2025·Application pending·0 cites
- 0959US2020085741A1Pharmaceutical composition for controlled release of weak acid drugs and uses thereofPHARMOSA BIOPHARM INC·Filed 2019·Application pending·0 cites
- 1056US12064406B2Pharmaceutical composition of a weak acid drug and methods of administrationPHARMOSA BIOPHARM INC·Filed 2020·Granted Aug 20, 2024·0 cites·26 claims
- 1153US2026069535A1Nebulizer kits and uses thereofPHARMOSA BIOPHARM INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →